Passage BIO (PASG) Assets (2019 - 2026)
Passage BIO (PASG) posted quarterly Assets of $36.5 million for Q1 2026, down 57.61% year-over-year from $86.0 million in Q1 2025, and down 41.46% quarter-over-quarter from $62.3 million in Q4 2025.
Passage BIO (PASG) Assets (2019 - 2026) Analysis & Trends
Passage BIO's Assets history runs 8 years deep, the most recent figure standing at $36.5 million for Q1 2026.
- In Q1 2026, Assets fell 57.61% year-over-year to $36.5 million; the TTM figure through Mar 2026 stood at $36.5 million (down 57.61% YoY), while the FY2025 annual figure was $62.3 million, down 39.19% from the prior year.
- Assets for Q1 2026 stood at $36.5 million, down from $62.3 million in the prior quarter.
- The five-year high for Assets was $333.2 million in Q1 2022, with the low at $36.5 million in Q1 2026.
- The 5-year median for Assets is $140.5 million (2024), against an average of $158.3 million.
- The sharpest annual moves came in 2022 and 2026: Assets declined 28.37% in 2022, then tumbled 57.61% in 2026.
- Passage BIO's Assets stood at $243.5 million in 2022, then sank by 38.19% to $150.5 million in 2023, then sank by 31.97% to $102.4 million in 2024, then plunged by 39.19% to $62.3 million in 2025, then plunged by 41.46% to $36.5 million in 2026.
- Business Quant data shows PASG's Assets at $36.5 million in Q1 2026, $62.3 million in Q4 2025, and $74.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 19.82 Bn |
| 10 | Passage BIO | 13.99 Mn | 13.99 Mn | - | 25.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.18 Mn |
| Mar 31, 2026 | 36.46 Mn |
| Dec 31, 2025 | 62.28 Mn |
| Sep 30, 2025 | 74.16 Mn |
| Jun 30, 2025 | 79.20 Mn |
| Mar 31, 2025 | 86.01 Mn |
| Dec 31, 2024 | 102.41 Mn |
| Sep 30, 2024 | 111.75 Mn |
| Jun 30, 2024 | 125.39 Mn |
| Mar 31, 2024 | 140.53 Mn |
| Dec 31, 2023 | 150.55 Mn |
| Sep 30, 2023 | 169.26 Mn |
| Jun 30, 2023 | 193.70 Mn |
| Mar 31, 2023 | 213.24 Mn |
| Dec 31, 2022 | 243.55 Mn |
| Sep 30, 2022 | 270.05 Mn |
| Jun 30, 2022 | 299.42 Mn |
| Mar 31, 2022 | 333.22 Mn |
| Dec 31, 2021 | 355.08 Mn |
| Sep 30, 2021 | 390.94 Mn |